Drug Landscape ›
genteal gel ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 153
Most-reported reactions
Eye Irritation — 34 reports (22.22%) Vision Blurred — 25 reports (16.34%) Ocular Hyperaemia — 22 reports (14.38%) Eye Pain — 20 reports (13.07%) Drug Ineffective — 14 reports (9.15%) Glaucoma — 10 reports (6.54%) Cataract — 8 reports (5.23%) Blindness — 7 reports (4.58%) Dry Eye — 7 reports (4.58%) Eye Swelling — 6 reports (3.92%)
Source database →
genteal gel in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is genteal gel approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for genteal gel in United States?
Lifelong Vision Foundation is the originator. The local marketing authorisation holder may differ — check the official source linked above.